• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ipca Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3617.0
  • ISIN : INE571A01038
1,450.20 -24 (-1.61%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,439.30

  • Today’s High

    1,489.40

  • Open

    1,484.10

  • Perv Close

    1,473.90

  • 52W Low

    1,168.20

  • 52W High

    1,755.90

Key Indicators

  • P/E(TTM)

    44.91

  • Mar.Cap (₹Cr.)

    36,792.19

  • Div & Yield %

    0.28

  • Book Value(₹)

    271.64

  • Debt-Equity Ratio

    -1.61

  • AGM Date

    01-Aug-2025

  • EPS

    32.33

  • P/E Ratio

    44.91

Financials Ratios

  • Debt-Equity Ratio

    0.24

  • Mar.Cap (₹Cr.)

    36,792.19

  • RONW (%)

    8.69

  • ROCE (%)

    12.92

Score Board

  • Equity (₹ in Cr.)

    25.37

  • BV (₹)

    271.60

  • Sales( ₹ in Cr.)

    6,677.92

  • NP (in Cr.)

    820.31

  • NP Var(%)

    37.0

  • Div%

    400.0

  • CPS (₹)

    42.30

  • EPS (₹)

    32.30

  • Traded Value (₹ in Lakhs)

    36,837.85

  • 52 Week High

    1,755.90

  • 52 Week Low

    1,168.20

  • Price BSE

    1452.0

  • Price NSE

    1,450.00

  • Market Capital( in Cr.)

    36,837.85

  • P/C Ratio

    34.40

  • P/E Ratio

    44.90

  • Price Vs.BV

    32.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 6,677.92 6,166.46 5,814.62 5,438.30 5,139.16 4,367.43
Excise Duty 0.00 0.00 0.00 0.00 0.00 29.61
Net Sales 6,677.92 6,166.46 5,814.62 5,438.30 5,139.16 4,337.82
Other Income 71.29 111.29 111.19 52.92 62.24 64.69
Stock Adjustments -128.43 55.19 -104.09 126.00 170.73 155.05
Total Income 6,620.78 6,332.94 5,821.72 5,617.22 5,372.13 4,557.56
EXPENDITURE :            
Raw Materials 1,764.88 2,033.57 1,964.94 1,911.88 1,753.21 1,635.75
Power and Fuel Cost 235.60 253.33 277.21 237.44 201.48 196.82
Employee Cost 1,479.34 1,336.19 1,193.39 1,102.14 948.84 870.79
Other Manufacturing Expenses 367.61 356.81 311.74 279.03 225.25 198.30
Selling and Administration Expenses 953.42 846.95 812.67 612.89 551.23 523.99
Miscellaneous Expenses 503.13 314.87 236.31 179.67 113.31 149.41
Employee Benefit Expenses 1,479.34 1,336.19 1,193.39 1,102.14 948.84 870.79
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,303.98 5,141.72 4,796.26 4,323.05 3,793.32 3,575.06
Operating Profit 1,316.80 1,191.22 1,025.46 1,294.17 1,578.81 982.50
Interest 65.06 122.58 46.34 10.41 11.13 18.84
Gross Profit 1,251.74 1,068.64 979.12 1,283.76 1,567.68 963.66
Depreciation 251.97 246.48 228.63 209.65 187.72 178.69
Profit Before Tax 999.77 822.16 750.49 1,074.11 1,379.96 784.97
Current Tax 340.90 288.01 223.95 197.28 244.98 137.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 8.11 3.74 20.84 16.46 -5.79 -5.47
Reported Net Profit 650.76 530.41 505.70 860.37 1,140.77 652.46
Extraordinary Items -169.55 -69.52 17.51 7.86 8.34 10.86
Adjusted Net Profit 820.31 599.93 488.19 852.51 1,132.43 641.60
Adjustment below Net Profit -4.92 -1.39 -2.05 1.15 -0.16 -107.04
P & L Balance brought forward 4,956.80 4,478.52 4,076.35 3,316.31 2,277.18 1,752.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 101.48 50.74 101.48 101.48 101.48 20.77
P & L Balance carried down 5,501.16 4,956.80 4,478.52 4,076.35 3,316.31 2,277.18
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 400.00 400.00 400.00 400.00 400.00 250.00
Dividend Per Share(Rs) 4.00 4.00 4.00 4.00 8.00 5.00
Earnings Per Share-Unit Curr 25.65 20.91 19.93 33.91 89.93 51.64
Earnings Per Share(Adj)-Unit Curr 25.65 20.91 19.93 33.91 44.97 25.82
Book Value 271.64 250.24 231.66 215.84 374.67 290.11
Book Value(Adj)-Unit Curr 271.64 250.24 231.66 215.84 187.34 145.06

Shareholding Pattern

  • Promoter Group

    44.72%

  • Public Share Holding

    55.28%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 95,423,418 37.61 95,423,418 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,044,054 7.11 18,044,054 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 113,467,472 44.72 113,467,472 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,130 0.00 130 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,065,840 10.67 27,057,840 201
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 14,787,064 5.83 14,787,064 14
Mutual Funds / UTI 75,120,106 29.61 75,116,106 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,932,337 0.76 1,932,337 21
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 118,907,477 46.87 118,893,477 270
2] Non Institution
Bodies Corporate 1,065,003 0.42 1,061,003 526
Clearing Members 3,602 0.00 3,602 9
Directors of their Relatives 43,700 0.02 43,700 2
Employees 25,000 0.01 0 11
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 8,000 0.00 8,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,173,932 0.46 1,171,730 2,361
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 810,823 0.32 808,823 1,356
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 17,303,038 6.82 16,609,004 80,957
Market Maker 2,000 0.00 2,000 1
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 17,395 0.01 17,395 6
Others 782,611 0.31 782,611 2
Sub Total 21,329,269 8.41 20,602,033 85,296
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 253,704,218 100.00 252,962,982 85,582

Company Background

Ipca Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ipca Laboratories Ltd
  • BSE Code : 3617.0
  • ISIN : INE571A01038

  • Incorporation Year

    1949

  • Registered Office

    48 Kandivli Industrial Estate
    Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66474444

  • FAX

    91-22-28686613

  • Chairman

    Premchand Godha

  • Managing Director

    A K Jain

  • Company Secretary

    Harish P Kamath

  • Auditor

    Natvarlal Vepari & Co. LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ipca Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ipca Labs. 1,452.00 6,749.21 6,677.92 56.61 17.21
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10